ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001

Talpin To Join NCI

June 27, 2003